CABA
Cabaletta Bio, Inc.
$3.12
-0.02 (-0.48%)
At close · Jul 9
Market Cap
$485.09M
Shares
163,054,796
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.12
Open$3.15
Day$3.01–3.24
52W$1.26–4.23
Avg vol 30d5.7M
Short int34.1M · 20.9% float · 4.3d
Short vol56%
Last earningsNov 14, 2024
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
−6%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
63%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−3%
trailing
6-month return
+45%
trailing
YTD return
+42%
this year
Relative strength
+36%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
1 of 112 funds reported for Jun 30 · net +7.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
20.89% of float · ▲ +29.8% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
112 holders — mid 3-yr range
Squeeze score
68
elevated · 0–100
Fundamentals
EPS growth
+10%
Y/Y
Free cash flow
$-132.3M
Balance sheet
$83.0M
net cash
Quant / Vol
risk profile
Volatility
102%
annualized · 1-yr
Max drawdown
−43%
past year
ATR
8.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
−6%
Bearish
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
63%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $3 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
1 of 112 funds reported for Jun 30 · net +7.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
20.89% of float · ▲ +29.8% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
112 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $3 · 63%
52-wk high $4
vs 200-day avg +10%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CABA
this stock
Cabaletta Bio, Inc.
|
$485.09M | +42.2% | — | — | 20.9% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CABA | +4.2% | -3.3% | +44.9% | +0.2% | +42.2% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +3.4% | -5.3% | +36.0% | -0.5% | +32.0% |